Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Harmony Biosciences Holdings (HRMY) Other financing activities (2019 - 2021)

Historic Other financing activities for Harmony Biosciences Holdings (HRMY) over the last 3 years, with Q4 2021 value amounting to $5000.0.

  • Harmony Biosciences Holdings' Other financing activities changed N/A to $5000.0 in Q4 2021 from the same period last year, while for Dec 2023 it was $22000.0, marking a year-over-year change of. This contributed to the annual value of $3.0 million for FY2023, which is N/A changed from last year.
  • Latest data reveals that Harmony Biosciences Holdings reported Other financing activities of $5000.0 as of Q4 2021.
  • Over the past 5 years, Harmony Biosciences Holdings' Other financing activities peaked at $5.8 million during Q1 2020, and registered a low of $5000.0 during Q4 2021.
  • In the last 3 years, Harmony Biosciences Holdings' Other financing activities had a median value of $446000.0 in 2019 and averaged $1.7 million.